Clinical Trial Update: PK-PD Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients

View source ↗

Summary

A pharmacokinetic and pharmacodynamic study of mycophenolate mofetil (CellCept) in pediatric kidney transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Kidney Transplant | Status: COMPLETED